Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IngevityNGVT -2.60%62 Receivables Turnover is 2.05 as of Jun. 2026. GuruFocus rates NGVT with a GF Score™ of 62/100 and a GF Value™ of $46.12 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,581 Chemicals companies, Ingevity ranks better than 66.92% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Ingevity's Revenue for the
three
months ended in Jun. 2026 was $314 Mil. Ingevity's average Accounts Receivable for the
three
months ended in Jun. 2026 was $154 Mil.
Hence, Ingevity's Receivables Turnover for the
three
months ended in Jun. 2026 was 2.05.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Ingevity Receivables Turnover Related Terms
Ingevity Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Ingevity's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGVT vs CC, KWR, MTX: Receivables Turnover Comparison
For the Specialty Chemicals subindustry, Ingevity's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ingevity Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Ingevity's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Ingevity's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ingevity (NGVT) has a Receivables Turnover of 2.05 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Ingevity and its competitors. According to the industry distribution chart, Ingevity ranks #523 out of 1581 companies in the Chemicals industry, placing it in the top 33.1%.
Is Ingevity's Receivables Turnover too high?
Ingevity's current Receivables Turnover is 2.05. The Chemicals industry median Receivables Turnover is 5.65. Ingevity's value of 2.05 is 63.7% below this industry median. Based on the distribution chart, Ingevity ranks #523 out of 1581 companies in the Chemicals industry, which is above the industry midpoint. Overall, Ingevity has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ingevity's Receivables Turnover compare to CC and KWR?
According to the Chemicals industry distribution chart, Ingevity ranks #523 out of 1581 companies for Receivables Turnover. This puts Ingevity in the upper half of its industry. The industry median Receivables Turnover is 5.65. Ingevity's value of 2.05 is 63.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.65, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ingevity's current Receivables Turnover of 2.05 is 63.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Ingevity and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ingevity's current Receivables Turnover is 2.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ingevity stock overvalued right now?
Based on GuruFocus' analysis, Ingevity (NGVT) is currently considered Significantly Overvalued. The stock's GF Value™ is $46.12, compared to a current price of $69.31 — trading 50.3% above its estimated fair value. The current Receivables Turnover is 2.05 and 63.7% below the Chemicals industry median of 5.65. Ingevity's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Ingevity (NGVT), the current Receivables Turnover is 2.05 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ingevity (NGVT) Overvalued in 2026?
Based on GuruFocus' analysis, Ingevity stock appears to be overvalued.
The current stock price of $69.31 is trading 50.3% above its estimated GF Value™ of $46.12.
GuruFocus considers Ingevity to be Significantly Overvalued.
Key valuation signals for NGVT:
Receivables Turnover: 2.05
GF Value™: $46.12 vs. price of $69.31 (50.3% above fair value)
Industry Position: 63.7% below the Chemicals median (#523 of 1581)
No single metric tells the full story. See the NGVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
62GF Score
Get the complete analysis for NGVT
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGVT has been successfully added to your 
